Two Executives Convicted in $300M CytoDyn Stock Fraud Scheme

https://img.particlenews.com/image.php?url=31c08v_0xKhbIjq00

A federal jury convicted two executives for defrauding investors and misleading the FDA about CytoDyn’s investigational drug, per DOJ.Photo bySangharsh LohakareonUnsplash

A federal jury in Maryland convicted two men Monday for their roles in a scheme to deceive investors in CytoDyn Inc., a publicly traded biotechnology company based in Vancouver, Washington, the U.S. Attorney’s Office, District of Maryland announced today.

Story continues

YOU MIGHT ALSO LIKE

TRENDING ARTICLES